IPP and autoimmune disease: Instead, it is reasonable to hypothesise that a proportion of subjects (i.e., 15%) may have had a preexisting infection or autoimmune disease which resulted in the exposure of IPP or another activating ligand which, inturn, may have primed the transient antigen-independent expansion of effector γδ+ T cells following ex vivo restimulation of PBMC.